OCT 26, 2019 9:37 AM PDT

Gates Foundation and NIH Pledge $200 Million for Gene Therapies in Africa

WRITTEN BY: Annie Lennon

Over the next four years, the National Institutes of Health and the Bill and Melinda Gates Foundation plan to each invest $100 million towards the development of gene therapy-based cures for sickle cell disease and HIV. In particular, they are focusing on making these treatments available in sub-Saharan Africa, where they are needed most. 

According to NIH Director Dr. Francis Collins, “This unprecedented collaboration focuses from the get-go on access, scalability and affordability of advanced gene-based strategies for sickle cell disease and HIV to make sure everybody, everywhere has the opportunity to be cured, not just those in high-income countries...We aim to go big or go home (Ducharme: 2019).”

Gene therapy research has made some significant advances in recent years. Already, it is being used to treat several diseases, from inherited blindness to neuromuscular disease and leukemia. And now, both animal studies and some clinical trials have suggested that gene therapy technology may be able to treat two highly prevalent diseases in Africa: sickle cell disease and HIV (Cohen: 2019). 

To treat sickle cell disease, the collaboration aims to use in vivo gene therapy to deliver a therapeutic gene or gene-editing tools directly into the body via vectors, such as inactive viruses of nanoparticles. According to Collins, the procedure should resemble a simple blood transfusion. 

Although studies are already underway investigating ways that viral vectors can be used to deliver healthy genes to various tissues in the body, so far, in vivo gene therapy has only been used to modify blood stem cells in animal models of certain diseases. Thus, the collaboration aims to build upon this research and build ways for this technology to work in people too. 

As for HIV, the collaboration hopes to quicken the development of direct injections of gene editing components to target the CCR5 gene in white blood cells. With two people already having been cured of the disease via this treatment, in crippling the CCR5 gene, HIV is unable to enter new host cells and thus has been shown to naturally peter out. According to Steven Deeks, a leading HIV cure researcher at the University of California, San Francisco, “The potential beauty of in vivo gene editing is that it might be given ultimately as a single shot, curing everyone in a scalable manner (Ibid.).”


Sources 

 

Ducharme, Jamie: Time 

Cohen, Jon et al.: Science

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
OCT 15, 2020
Plants & Animals
Meet the World's First Cloned Przewalski's Horse
OCT 15, 2020
Meet the World's First Cloned Przewalski's Horse
Say “hello!” to Kurt, a two-month-old Przewalski’s horse that has made scientific history as the world ...
OCT 20, 2020
Genetics & Genomics
The Gene Behind the Glow of the Sea Pickle is ID'ed
OCT 20, 2020
The Gene Behind the Glow of the Sea Pickle is ID'ed
In this photo by OceanX, researchers off the coast of Brazil collected Pyrosoma atlanticum specimens with a special robo ...
OCT 24, 2020
Genetics & Genomics
Cord Blood Samples Reveal More About the Genetics of Autism
OCT 24, 2020
Cord Blood Samples Reveal More About the Genetics of Autism
The activity of genes in our genome is controlled by many factors, one of which are chemical tags or structural changes ...
NOV 09, 2020
Genetics & Genomics
Potential Problems with Liquid Biopsies
NOV 09, 2020
Potential Problems with Liquid Biopsies
Liquid biopsies are tests that look for biomarkers in the blood, which can help inform the treatment of cancer. The tool ...
NOV 27, 2020
Genetics & Genomics
Gravity Affects Gene Expression
NOV 27, 2020
Gravity Affects Gene Expression
If people are going to explore deep space, we should learn more about the effects that such an environment would potenti ...
DEC 26, 2020
Clinical & Molecular DX
Navigating the Genomic Landscape of Cancer in Asians
DEC 26, 2020
Navigating the Genomic Landscape of Cancer in Asians
Precision medicine — a clinical paradigm that tailors treatments specifically to patients based on their genetic a ...
Loading Comments...